The route of delivery gets the antisense ... The technology, the ThecaFlex DRx System, is an implantable device designed to enable the routine subcutaneous administration of drugs to the ...

Global Implantable Infusion Pump Market Set for Steady Growth from 2022 to 2032, Driven by Chronic Disease Management and Technological Advances. The global implantable infusion pump market is poised ...

Subcutaneous implants are injectable drug delivery systems effective for treatments lasting weeks to years. These implants ensure the active pharmaceutical ingredient (API) is released precisely where ...

About SP-26 Silo’s SP-26 is a ketamine-based injectable dissolvable polymer implant for the treatment of chronic pain and fibromyalgia. The subcutaneous implant is being designed to safely ...

Researchers headed by a team at the California Institute of Technology developed an ultrasound-guided 3D printing technique that could make it possible to fabricate medical implants in vivo and ...

Lundbeck has stopped development of a subcutaneous formulation of its migraine drug Lu AG09222 as the Danish drugmaker switches its focus to intravenous delivery after seeing phase 2b data ...

If the subcutaneous delivery method gains approval, an advantage daratumumab holds over isatuximab would be removed. A subcutaneous (SC) formulation of isatuximab (Sarclisa, Sanofi) was found to ...

"Our technology can ease the burden of treatment and improve patient outcomes by making possible rapid, high-volume subcutaneous drug delivery for patients with serious medical conditions." ...

Subcutaneous amivantamab is co-formulated Halozyme's ENHANZE ® drug delivery technology. "We are delighted to announce the European approval of the subcutaneous formulation of amivantamab ...

Tecentriq Hybreza, a subcutaneous delivery of the drug, was approved for certain types of sarcoma, in addition to lung, skin and liver cancers. The Food and Drug Administration (FDA) approved ...

today announced a collaboration agreement with Kymanox for specialized design and development of a subcutaneous insertion device for SP-26, the Company’s ketamine-loaded implant ...